Development of a New Biofidelity Ranking System for Anthropomorphic Test Devices 2002-22-0024
A new biofidelity assessment system is being developed and applied to three side impact dummies: the WorldSID-α, the ES-2 and the SID-HIII. This system quantifies (1) the ability of a dummy to load a vehicle as a cadaver does, “External Biofidelity,” and (2) the ability of a dummy to replicate those cadaver responses that best predict injury potential, “Internal Biofidelity.” The ranking system uses cadaver and dummy responses from head drop tests, thorax and shoulder pendulum tests, and whole body sled tests. Each test condition is assigned a weight factor based on the number of human subjects tested to form the biomechanical response corridor and how well the biofidelity tests represent FMVSS 214, side NCAP (SNCAP) and FMVSS 201 Pole crash environments. For each response requirement, the cumulative variance of the dummy response relative to the mean cadaver response (DCV) and the cumulative variance of the mean cadaver response relative to the mean plus one standard deviation (CCV) are calculated. The ratio of DCV/CCV expresses how well the dummy response duplicates the mean cadaver response: a smaller ratio indicating better biofidelity. For each test condition, the square root is taken of each Response Comparison Value (DCV/CCV), and then these values are averaged and multiplied by the appropriate Test Condition Weight. The weighted and averaged comparison values are then summed and divided by the sum of the Test Condition Weights to obtain a rank for each body region. Each dummy obtains an overall rank for External Biofidelity and an overall rank for Internal Biofidelity comprised of an average of the ranks from each body region. Of the three dummies studied, the selected comparison test data indicate that the WorldSID-α prototype dummy demonstrated the best overall External Biofidelity although improvement is needed in all of the dummies to better replicate human kinematics. All three dummies estimate potential injury assessment with similar levels of Internal Biofidelity.